INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH, BANGLADESH
🇧🇩Bangladesh
- Country
- 🇧🇩Bangladesh
- Ownership
- Private
- Established
- 1978-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.icddrb.org
Clinical Trials
196
Active:1
Completed:126
Trial Phases
6 Phases
Early Phase 1:2
Phase 1:17
Phase 2:31
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (186 trials with phase data)• Click on a phase to view related trials
Not Applicable
103 (55.4%)Phase 2
31 (16.7%)Phase 3
22 (11.8%)Phase 1
17 (9.1%)Phase 4
11 (5.9%)Early Phase 1
2 (1.1%)Assessing the Safety and Efficacy of a Combination Therapy for STH in PSAC in Bangladesh
Not Applicable
Not yet recruiting
- Conditions
- Soil Transmitted Helminth (STH) Infections
- Interventions
- Drug: A single dose of Albendazole 400mg + Ivermectin (200 µg/ kg) combination therapyDrug: A single dose of 400 mg Oral Albendazole monotherapy
- First Posted Date
- 2025-07-01
- Last Posted Date
- 2025-07-18
- Target Recruit Count
- 110
- Registration Number
- NCT07045493
Every Newborn Reach Up Early Education Intervention for All Children Education (ENREACH) Education
Not Applicable
Not yet recruiting
- Conditions
- School ReadinessSchool Environment
- First Posted Date
- 2025-03-21
- Last Posted Date
- 2025-06-26
- Target Recruit Count
- 3000
- Registration Number
- NCT06890156
- Locations
- 🇧🇩
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh
Maternal Probiotic Intervention to Improve Gut Health - Trial II - Bangladesh
Phase 2
Not yet recruiting
- Conditions
- Environmental Enteric Dysfunction
- Interventions
- First Posted Date
- 2025-02-10
- Last Posted Date
- 2025-04-22
- Target Recruit Count
- 144
- Registration Number
- NCT06817031
- Locations
- 🇧🇩
International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Matlab, Bangladesh
Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months
Phase 3
Not yet recruiting
- Conditions
- MeaslesRubellaYellow Fever
- Interventions
- Biological: Measles-Rubella vaccine (Live) I.P. (Freeze Dried) of M/s. Zydus Lifesciences LtdBiological: Yellow fever Vaccine (WHO prequalified)
- First Posted Date
- 2025-02-07
- Last Posted Date
- 2025-02-07
- Target Recruit Count
- 1530
- Registration Number
- NCT06815835
- Locations
- 🇧🇩
Icddr,B, Dhaka, Bangladesh
ZyVac-TCV Bangladesh Study
Phase 3
Not yet recruiting
- Conditions
- Typhoid VaccinationTyphoidTyphoid Fever
- First Posted Date
- 2025-01-03
- Last Posted Date
- 2025-02-07
- Target Recruit Count
- 4000
- Registration Number
- NCT06757283
- Locations
- 🇧🇩
International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh
- Prev
- 1
- 2
- 3
- 4
- 5
- 39
- Next
News
WHO Approves Single-Dose Cecolin HPV Vaccine Following Landmark Trial
The WHO has approved Cecolin, a bivalent HPV vaccine, for single-dose use, potentially revolutionizing cervical cancer prevention efforts globally.